Profile
Craig West worked as Research Director at Guggenheim Partners LLC from 2004 to 2015.
Served as Senior Director-Investor Relations at BeOne Medicines Ltd. from 2018 to 2021.
Held the position of Senior Vice President-Investor Relations at Nanobiotix SA. Worked as Partner at A.G.
Edwards & Sons, Inc. Held the role of Vice President-Investor Relations at Epizyme, Inc. in 2021.
Served as Vice President-Investor Relations & Communications at Curis, Inc. in 2022.
Former positions of Craig West
| Companies | Position | End |
|---|---|---|
| NANOBIOTIX | Investor Relations Contact | 30/04/2025 |
| CURIS, INC. | Investor Relations Contact | 31/10/2022 |
| EPIZYME, INC. | Investor Relations Contact | 31/10/2021 |
| BEIGENE LTD | Investor Relations Contact | 28/02/2021 |
Guggenheim Partners LLC
Guggenheim Partners LLC Investment ManagersFinance Provides investment and financial services | Chief Tech/Sci/R&D Officer | 30/04/2015 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
A.G. Edwards & Sons, Inc.
A.G. Edwards & Sons, Inc. Investment Banks/BrokersFinance Provides brokerage dealing services | Finance |
Curis, Inc.
Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Guggenheim Partners LLC
Guggenheim Partners LLC Investment ManagersFinance Provides investment and financial services | Finance |
Nanobiotix SA
Nanobiotix SA Pharmaceuticals: MajorHealth Technology Develops and manufactures nanotherapeutics for treatment of cancer | Health Technology |
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
BeiGene Ltd.
BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Craig West
















